Register For FREE
on SteadyHealth.com
On Thursday, the WHO issued revised guidance for the clinical management of H1N1 (swine) flu, the Associated Press reports.
U.S. government data released on Monday confirmed that a single dose of the vaccine protects pregnant women from the virus, while children under the age of 10 years need two doses of the vaccine, the Washington Post reports.
Source: National Institute of Mental Health Related MedlinePlus Topic: Fragile X Syndrome
NIH's National Institute of Allergy and Infectious Diseases launched a clinical trial last week to examine the effectiveness of an experimental H1N1 influenza vaccine in pregnant women, a group that health officials consider one of the most susceptible to the disease, CQ HealthBeat reports.
Karolinska Development (publ) announced that one of its portfolio companies, Dilafor AB, has concluded an extensive clinical study of its candidate drug, tafoxiparin, a new drug substance for the prevention of protracted labor during childbirth. The promising results of the Phase II trial bring the project closer to exit in line with Karolinska Development's business strategy.